|
|
||||||||
Journal of Lipid Research, Vol 28, 1098-1109, Copyright © 1987 by Lipid Research, Inc.
O Wiklund, JL Witztum, TE Carew, RC Pittman, RL Elam and D Steinberg
Immunological mechanisms have been implicated in the atherogenic process
since immunoglobulins are frequently found in the atherosclerotic aorta. We
have previously shown that modifications of homologous low density
lipoproteins (LDL) make it immunogenic. In particular we have demonstrated
that immunization with homologous nonenzymatically glucosylated LDL
(glcLDL) results in the generation of antibodies specific to the
derivatized lysine residue, and that such antibodies do not react with
native LDL epitopes. In the present study we immunized rabbits with
reductively glucosylated rabbit LDL and then determined the effects of the
circulating antibodies on the rates of plasma clearance and on the sites of
degradation of LDL in which varying degrees of glucosylation had been
achieved. In normal chow-fed animals, the plasma clearance of glcLDL was
retarded in proportion to the extent of lysine derivatization. In contrast,
in immunized animals the clearance of glcLDL was greatly accelerated. When
10% or more of lysine residues were derivatized, clearance of glcLDL was
accelerated 50- to 100-fold. Even when only 5% of lysines were derivatized,
plasma clearance was accelerated 2- to 3-fold. Cholesterol feeding
inhibited LDL clearance from plasma and decreased LDL uptake of LDL
receptor-rich tissues. In a similar manner, glucosylation of LDL inhibited
its ability to bind to the LDL receptor and redirected sites of LDL
degradation away from LDL receptor-rich tissues. Thus degradation of glcLDL
by liver and adrenal was markedly diminished. The presence of antibodies to
glcLDL also redirected sites of degradation of the modified LDL, primarily
to the reticuloendothelial cells of the liver. There was no evidence for
specific targeting of glcLDL-immunoglobulin complexes to the aorta; instead
they were targeted to the liver. These data suggest that the presence of
humoral antibodies to modified LDL acts to rapidly remove such LDL from
plasma and specifically targets such complexes to reticuloendothelial
cells, primarily in the liver. In this manner such antibodies may serve a
useful purpose.
ARTICLES
Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
Department of Medicine, University of California, San Diego, La Jolla 92093.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. A. Reardon, E. R. Miller, L. Blachowicz, J. Lukens, C. J. Binder, J. L. Witztum, and G. S. Getz Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice J. Lipid Res., July 1, 2004; 45(7): 1347 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Karvonen, M. Paivansalo, Y. A. Kesaniemi, and S. Horkko Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis Circulation, October 28, 2003; 108(17): 2107 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Hedrick, K. Hassan, G. P. Hough, J. Yoo, S. Simzar, C. R. Quinto, S.-M. Kim, A. Dooley, S. Langi, S. Y. Hama, et al. Short-Term Feeding of Atherogenic Diet to Mice Results in Reduction of HDL and Paraoxonase That May Be Mediated by an Immune Mechanism Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1946 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukumoto, T. Shoji, M. Emoto, T. Kawagishi, Y. Okuno, and Y. Nishizawa Antibodies Against Oxidized LDL and Carotid Artery Intima-Media Thickness in a Healthy Population Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 703 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shih, Y.-R. Xia, X.-P. Wang, E. Miller, L. W. Castellani, G. Subbanagounder, H. Cheroutre, K. F. Faull, J. A. Berliner, J. L. Witztum, et al. Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis J. Biol. Chem., June 2, 2000; 275(23): 17527 - 17535. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |